Jeannine S Skinner1, Amy Morgan2, Hector Hernandez-Saucedo3, Angela Hansen4, Selena Corbett2, Matthew Arbuckle2, James Ba Leverenz5, Consuelo H Wilkins1, Suzanne Craft3, Laura D Baker3. 1. Meharry-Vanderbilt Alliance, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA. 3. Department of Internal Medicine, and Neurology, Wake Forest University Health Sciences, Winston-Salem, NC, USA. 4. Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA; Division of Gerontology, Geriatric Medicine, University of Washington School of Medicine, USA. 5. Lou Ruvo Center for Brain Health, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Abstract
BACKGROUND: Glucose and insulin are important moderators of cognitive function. African Americans have poorer glycemic control across the glycemic spectrum and are at increased risk for type 2 diabetes and poor cognitive health. It is unclear which glucoregulatory markers predict cognitive function in this at-risk population. The purpose of this study was to examine the association between cognitive function and common markers of glucoregulation in non-diabetic African Americans elders. METHODS: Thirty-four, community-dwelling African Americans, aged 50-75 years completed cognitive testing and blood collection as part of a health screening assessment. Cognitive outcomes were composite scores derived from neuropsychological tests of executive function and verbal memory. Linear regression was used to examine relationships between cognitive composite scores and fasting blood levels of glucose, insulin, and hemoglobin A1C, with adjustments for age, education, body mass index, and antihypertensive medication use. RESULTS: Fasting plasma glucose was negatively associated with executive function (β=-0.41, p=0.03). There was a trend of an association between fasting plasma glucose and verbal memory (β=-0.34, p=0.06). Fasting insulin and hemoglobin A1c were not associated with cognitive function. CONCLUSION: High non-diabetic fasting glucose levels were associated with poorer executive function and verbal memory. These results provide preliminary support for proactive glucose control in older African Americans even before glycemic criteria for type 2 diabetes are met. Our findings suggests that high-normal FPG levels may represent an early red-flag to signify increased risk of cognitive impairment or decline.
BACKGROUND:Glucose and insulin are important moderators of cognitive function. African Americans have poorer glycemic control across the glycemic spectrum and are at increased risk for type 2 diabetes and poor cognitive health. It is unclear which glucoregulatory markers predict cognitive function in this at-risk population. The purpose of this study was to examine the association between cognitive function and common markers of glucoregulation in non-diabetic African Americans elders. METHODS: Thirty-four, community-dwelling African Americans, aged 50-75 years completed cognitive testing and blood collection as part of a health screening assessment. Cognitive outcomes were composite scores derived from neuropsychological tests of executive function and verbal memory. Linear regression was used to examine relationships between cognitive composite scores and fasting blood levels of glucose, insulin, and hemoglobin A1C, with adjustments for age, education, body mass index, and antihypertensive medication use. RESULTS: Fasting plasma glucose was negatively associated with executive function (β=-0.41, p=0.03). There was a trend of an association between fasting plasma glucose and verbal memory (β=-0.34, p=0.06). Fasting insulin and hemoglobin A1c were not associated with cognitive function. CONCLUSION: High non-diabetic fasting glucose levels were associated with poorer executive function and verbal memory. These results provide preliminary support for proactive glucose control in older African Americans even before glycemic criteria for type 2 diabetes are met. Our findings suggests that high-normal FPG levels may represent an early red-flag to signify increased risk of cognitive impairment or decline.
Entities:
Keywords:
African Americans; Executive function; Glucose; Memory; Type 2 diabetes
Authors: Ha T Nguyen; Joseph G Grzywacz; Thomas A Arcury; Christine Chapman; Julienne K Kirk; Edward H Ip; Ronny A Bell; Sara A Quandt Journal: J Am Geriatr Soc Date: 2010-06 Impact factor: 5.562
Authors: Iciar Martín-Timón; Cristina Sevillano-Collantes; Amparo Segura-Galindo; Francisco Javier Del Cañizo-Gómez Journal: World J Diabetes Date: 2014-08-15
Authors: Marieke van Oijen; Olivia I Okereke; Jae Hee Kang; Michael N Pollak; Frank B Hu; Susan E Hankinson; Francine Grodstein Journal: Neuroepidemiology Date: 2008-04-17 Impact factor: 3.282
Authors: Laura D Baker; Suzanne M Barsness; Soo Borson; George R Merriam; Seth D Friedman; Suzanne Craft; Michael V Vitiello Journal: Arch Neurol Date: 2012-11
Authors: Wesley Farris; Stefan Mansourian; Yang Chang; Loren Lindsley; Elizabeth A Eckman; Matthew P Frosch; Christopher B Eckman; Rudolph E Tanzi; Dennis J Selkoe; Suzanne Guenette Journal: Proc Natl Acad Sci U S A Date: 2003-03-12 Impact factor: 11.205
Authors: Jane A Lonie; Lucie L Herrmann; Kevin M Tierney; Claire Donaghey; Ronan O'Carroll; Andrew Lee; Klaus P Ebmeier Journal: J Neuropsychol Date: 2009-03 Impact factor: 2.864